SARS-CoV-2 Virus like Particles produced by a single recombinant baculovirus generate potent neutralizing antibody that protects against variant challenge

First Author: Edward Sullivan

Attributed to: Development of a highly sensitive serological assay for Covid-19 based on the use of virus-like particles and protein-based nanoparticles. funded by COVID

No abstract provided

Type: Journal Article/Review

Parent Publication: TBC